This is the protocol for a review and there is no abstract. The objectives are as follows:, (1)To review the efficacy of calcitonin versus placebo in the treatment of postmenopausal osteoporosis, using the outcomes: bone mineral density, and fractures., (2)To assess the quality of the studies in this area., (3)To assess the use of calcitonin for primary prevention (women who have not sustained a fracture) and for secondary prevention (women who have had a previous fracture)